Status:
RECRUITING
Healthy Early Life Moments in Singapore
Lead Sponsor:
KK Women's and Children's Hospital
Collaborating Sponsors:
Lien Foundation
Conditions:
Metabolic Disease
Mental Health Wellness 1
Eligibility:
FEMALE
21-40 years
Phase:
NA
Brief Summary
This study aims to assess whether an integrated continuum of care from the preconception period, across maternity until the first 18 months of life, can promote maternal metabolic and mental health, a...
Detailed Description
Maternal Child Health (MCH) in Singapore is currently entering a new phase to address the twin challenges; a burgeoning (i) Metabolic and (ii) Mental Health Challenge for Singapore which have shown to...
Eligibility Criteria
Inclusion
- Women aged 21-40 years
- BMI 25-40 kg/m2
- Intention to reside in Singapore for the next 4 years
- Chinese, Malay, Indian or any combination of these 3 ethnic groups
- Planning to conceive within 1 year
- Able to understand English
- Able to provide written, informed consent
Exclusion
- Currently pregnant
- Known type 1 or type 2 diabetes
- On any anticonvulsant medication in the past 1 month
- On any oral steroid in the past 1 month (e.g. Prednisolone, Prednisone, Deltasone, Prelone, Methyl Prednisolone, Medrol, Hydrocortisone, Cortef, Dexamethasone, Decadron)
- On any oral, implanted contraception or intrauterine contraceptive device (IUCD) in situ in the past 1 month
- On any fertility medication (e.g. hormones injection, IVF treatments) other than Clomiphene/ Letrozole in the past 1 month
- On HIV or Hepatitis B or C medication in the past 1 month.
Key Trial Info
Start Date :
March 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05207059
Start Date
March 18 2022
End Date
December 1 2028
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KK Women's and Children's Hospital
Singapore, Singapore, 229899